Intellia Therapeutics Inc (NASDAQ:NTLA)
| 54.03 Delayed Data As of Jul 01 |  +2.27 / +4.39%Today’s Change | 37.08 Today|||52-Week Range 180.59 | -54.30% Year-to-Date |
Largest transactions by value over
| Name | Type | Date | Shares traded | Share price | Transaction value | Since transaction |
|---|---|---|---|---|---|---|
Leonard John M President & Chief Executive Officer |  Sale | 9/01/2021 | 44,735 | $170.00 | $7.6M | -67.08% |
Leonard John M President & Chief Executive Officer | Sale | 8/31/2021 | 37,833 | $155.00 | $5.9M | -66.36% |
Sepp Lorenzino Laura Chief Science Officer & EVP | Sale | 8/30/2021 | 28,669 | $154.77 | $4.4M | -64.92% |
Goddard Glenn /archemix/ Chief Financial Officer & Executive Vice President | Sale | 8/31/2021 | 24,800 | $160.22 | $4.0M | -66.36% |
Sepp Lorenzino Laura Chief Science Officer & EVP | Sale | 8/30/2021 | 20,645 | $153.64 | $3.2M | -64.92% |
Leonard John M President & Chief Executive Officer | Sale | 8/23/2021 | 18,874 | $151.54 | $2.9M | -65.83% |
Sepp Lorenzino Laura Chief Science Officer & EVP | Sale | 8/30/2021 | 16,115 | $155.61 | $2.5M | -64.92% |
Leonard John M President & Chief Executive Officer | Sale | 8/30/2021 | 15,567 | $155.70 | $2.4M | -64.92% |
Sepp Lorenzino Laura Chief Science Officer & EVP | Sale | 8/30/2021 | 15,839 | $152.75 | $2.4M | -64.92% |
Goddard Glenn /archemix/ Chief Financial Officer & Executive Vice President | Sale | 8/05/2021 | 9,902 | $150.65 | $1.5M | -67.30% |
Page of 9